Elite in Age-Related Macular Degeneration (ARMD)

Peter J. Kertes

2075 Bayview Avenue, M4N 3M5, 
Toronto, CA 
Elite in Age-Related Macular Degeneration (ARMD)
2075 Bayview Avenue, M4N 3M5, 
Toronto, CA 
OverviewLocationsClinical Research

Overview

Peter Kertes practices in Toronto, Canada. Mr. Kertes is rated as an Elite expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 169 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 42 articles in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

2075 Bayview Avenue, M4N 3M5, Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Evaluation of a Metabolic Hyperspectral Retinal Camera (MHRC) in Spectrally Resolved Reflectance and Fluorescence Imaging in a Diverse Population
Evaluation of a Metabolic Hyperspectral Retinal Camera (MHRC) in Spectrally Resolved Reflectance and Fluorescence Imaging in a Diverse Population
Enrollment Status: Withdrawn
Publish Date: March 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Beta-amyloid Plaques of the Retina Using Metabolic Hyperspectral Retinal Camera (MHRC) in Alzheimer's Patients - Toronto Study Arm
Evaluation of Beta-amyloid Plaques of the Retina Using Metabolic Hyperspectral Retinal Camera (MHRC) in Alzheimer's Patients - Toronto Study Arm
Enrollment Status: Completed
Publish Date: March 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Multicentre Randomized Clinical Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Peeling
A Multicentre Randomized Clinical Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Peeling
Enrollment Status: Terminated
Publish Date: September 21, 2018
Intervention Type: Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

169 Total Publications

Comparative Analysis of Ocular Adverse Events Associated with Aflibercept 8 mg and Faricimab: A Global Population-Based Study Across 65 Countries.
Comparative Analysis of Ocular Adverse Events Associated with Aflibercept 8 mg and Faricimab: A Global Population-Based Study Across 65 Countries.
Journal: Ophthalmology. Retina
Published: September 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kertes's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile